MedTrace Logo

Identification of Molecular Defects in Idiopathic Cytopenia of Undetermined Significance

NCT02804984 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2018-08-03

No results posted yet for this study

Summary

The project's objective is to identify and characterize somatic mutations in cases of idiopathic cytopenia of undetermined significance (ICUS) on the basis of molecular defects found in myelodysplastic syndrome (MDS), in order to validate the hypothesis whereby ICUS may be a precursor of MDS

Conditions

Interventions

GENETIC

ICUS

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Bérengère GRUSON, PhD · CHU Amiens

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02804984 on ClinicalTrials.gov